Validation and Agreement of the Taiwanese Versions of the Questionnaire of Olfactory Disorders–Negative Statements and Its Short Version

Man-Wei Hua ORCID ,  Kae-Shiuan Tsai ORCID ,  Rong-San Jiang ORCID
    Received: 3 August 2026; Revised: 11 September 2026; Accepted: 28 September 2026; Published: 30 September 2026

    Abstract

    Olfactory dysfunction (OD) is a common sensory disorder that can substantially impair daily functioning and quality of life, yet objective psychophysical testing does not fully capture its patient-perceived burden. This prospective validation study translated and culturally adapted the Questionnaire of Olfactory Disorders–Negative Statements (QOD-NS) and its seven-item short version (svQOD-NS) into Traditional Chinese and evaluated their validity, reproducibility, and agreement. Between June 2025 and April 2026, 120 participants were enrolled at Taichung Veterans General Hospital, including 40 normosmic volunteers, 40 patients with hyposmia, and 40 with anosmia. All participants completed both questionnaires in randomized order. Normosmic participants repeated both questionnaires after at least 1 week. Olfactory function was classified using a phenyl ethyl alcohol odor detection threshold test. Mean item scores were compared across groups, and agreement was evaluated with paired comparisons, Bland–Altman analysis, and Spearman rank correlations. Both Taiwan-adapted Traditional Chinese instruments clearly discriminated participants with olfactory dysfunction from normosmic participants (p < 0.05), whereas neither instrument significantly differentiated hyposmia from anosmia. Test–retest identical mean-item-score agreement was 80.0% for QOD-NS and 92.5% for svQOD-NS; repeated administrations also showed strong positive rank correlations. No significant differences were observed between QOD-NS and svQOD-NS mean item scores in any group (p = 0.125, 0.316, and 0.930), and Spearman correlations between the instruments were 0.72, 0.87, and 0.86 for normosmia, hyposmia, and anosmia, respectively (all p < 0.001). Bland–Altman analysis showed minimal bias. The Taiwan-adapted Traditional Chinese QOD-NS and svQOD-NS demonstrated satisfactory construct validity, temporal reproducibility, and strong agreement. The svQOD-NS may therefore provide a practical lower-burden alternative for routine clinical assessment and research in Taiwanese populations.

    Keywords

    References

    1. 1. Yang, J.; Pinto, J.M. The epidemiology of olfactory disorders. Curr. Otorhinolaryngol. Rep. 2016, 4, 130–141.
    2. 2. Passali, C.G.; Santantonio, M.; Passali, D. The current possibilities of diagnosing and therapies for olfactory disorders. Expert Opin. Pharmacother. 2024, 25, 973–983.
    3. 3. Hernandez, A.K.; Landis, B.N.; Altundag, A.; et al. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination. ORL J. Otorhinolaryngol. Relat. Spec. 2023, 85, 312–320.
    4. 4. Cameron, E.L.; Møller, P.; Karn, K.S. Effects of COVID-19 on sense of smell: Human factors/ergonomics considerations. Hum. Factors 2023, 65, 759–765.
    5. 5. Helman, S.N.; Adler, J.; Jafari, A.; et al. Treatment strategies for postviral olfactory dysfunction: A systematic review. Allergy Asthma Proc. 2022, 43, 96–105.
    6. 6. Auinger, A.B.; Besser, G.; Liu, D.T.; et al. Long-term impact of olfactory dysfunction on daily life. Wien Klin. Wochenschr. 2021, 133, 1004–1011.
    7. 7. Simopoulos, E.; Katotomichelakis, M.; Gouveris, H.; et al. Olfaction-associated quality of life in chronic rhinosinusitis: Adaptation and validation of an olfaction-specific questionnaire. Laryngoscope 2012, 122, 1450–1454.
    8. 8. Mattos, J.L.; Schlosser, R.J.; Storck, K.A.; et al. Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 2017, 7, 734–740.
    9. 9. Zou, L.-Q.; Hummel, T.; Otte, M.S.; et al. Association between olfactory function and quality of life in patients with olfactory disorders: A multicenter study in over 760 participants. Rhinology 2021, 59, 164–172.
    10. 10. Lechner, M.; Fjaeldstad, A.; Rehman, U.; et al. The development and validation of the Smell-Qx questionnaire, based on a systematic review of the literature and the COMET initiative on the development of core outcome sets for clinical trials in olfactory disorders. Int. Forum Allergy Rhinol. 2025, 15, 974–984.
    11. 11. Rovira-Martínez, C.; Campos-Motamayor, M.; Sansa-Perna, A.; et al. Assessment of the impact of post-COVID-19 olfactory dysfunction on quality of life: Comparison of specific questionnaires. Acta Otorrinolaringol. Esp. (Engl. Ed.) 2026, 77, 512312.
    12. 12. Yuan, F.; Wu, D.; Wei, Y. Predictive significance of the Questionnaire of Olfactory Disorders-Negative Statements for olfactory loss in patients with chronic rhinosinusitis. Eur. Arch. Otorhinolaryngol. 2022, 279, 5253–5262.
    13. 13. Shu, C.H.; Lee, P.O.; Lan, M.Y.; et al. Factors affecting the impact of olfactory loss on the quality of life and emotional coping ability. Rhinology 2011, 49, 337–341.
    14. 14. Lee, J.J.; Mahadev, A.; Kallogjeri, D.; et al. Development and psychometric validation of the Olfactory Dysfunction Outcomes Rating. JAMA Otolaryngol. Head Neck Surg. 2022, 148, 1132–1139.
    15. 15. Cardella, A.; Riva, G.; Preti, A.; et al. Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD). Acta Otorhinolaryngol. Ital. 2023, 43, 252–261.
    16. 16. Zou, L.; Haehner, A.; Menzel, S.; et al. Reliability and validity of a brief version of the Questionnaire of Olfactory Disorders (brief QOD) in patients with olfactory dysfunction. Rhinology 2022, 60, 56–62.
    17. 17. Alsayid, H.; Alnakhli, S.; Marzouki, H.Z.; et al. Arabic translation and validation of olfactory-specific quality of life assessment questionnaire. Cureus 2021, 13, e16000.
    18. 18. Ainer, I.; Husain, S.B.; Khairiyah, A.; et al. Validity and reliability of the Malay short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS). Egypt J. Otolaryngol. 2022, 38, 74.
    19. 19. Leclercq, C.; Chiesa-Estomba, C.M.; Horoi, M.; et al. Validity and reliability of the French short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS). Ear Nose Throat J. 2024, 103, NP113–NP117.
    20. 20. Tuz-Hrycyna, N.; Rzepakowska, A.; Niemczyk, K. Reliability and validity of the Polish version of the Questionnaire of Olfactory Disorders. Laryngoscope Investig. Otolaryngol. 2023, 8, 799–807.
    21. 21. Alsaleh, S.; Alfallaj, R.; Almousa, H.; et al. Reliability and validity of the Arabic version of the brief version of the Questionnaire of Olfactory Disorders. Laryngoscope Investig. Otolaryngol. 2024, 9, e1252.
    22. 22. Chiesa-Estomba, C.M.; Lechien, J.R.; Calvo-Henríquez, C.; et al. Translation and validation of the short version of the Questionnaire of Olfactory Disorders-Negative Statements to Spanish. Am. J. Otolaryngol. 2021, 42, 102775.
    23. 23. Pirola, F.; Giombi, F.; Ferreli, F.; et al. Cross-cultural validation of the short version of the Questionnaire of Olfactory Disorders-Negative Statements into Italian: Towards personalized patient care. J. Pers. Med. 2022, 12, 2010.
    24. 24. da Silva Bernardino, A.B.C.; Barreto-Filho, M.A.; Pompeu, A.S.; et al. Validation of the questionnaire of olfactory disorders (QOD) for the Brazilian population. Clinics (Sao Paulo) 2024, 79, 100414.
    25. 25. Guillemin, F.; Bombardier, C.; Beaton, D. Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J. Clin. Epidemiol. 1993, 46, 1417–1432.
    26. 26. Al-Ebrahim, S.Q.; Harrison, J.; Chen, T.F.; et al. Cross-cultural adaptation of patient-reported outcome measures: Methodological guidance for a better practice. Res. Social Adm. Pharm. 2026, 22, 459–464.
    27. 27. Jiang, R.-S.; Yan, K.; Chiang, Y.-F.; et al. The effect of Chinese herbal medicine on traumatic anosmia: A prospective, randomized clinical trial. Laryngoscope 2023, 133, 1473–1479.
    28. 28. Philpott, C.; Kumaresan, K.; Fjaeldstad, A.W.; et al. Developing a core outcome set for clinical trials in olfactory disorders: A COMET initiative. Rhinology 2023, 61, 312–319.
    ×